Sale!

GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the GDF2 gene responsible for Hereditary Hemorrhagic Telangiectasia Type 5 (HHT5). This advanced next-generation sequencing test provides crucial information for individuals experiencing recurrent nosebleeds, skin telangiectasias, or arteriovenous malformations. The test helps confirm diagnosis, assess family risk, and guide appropriate medical management. For only $500 USD, patients gain access to state-of-the-art genetic testing with detailed analysis of the GDF2 gene variants. Results are delivered within 3-4 weeks, providing valuable insights for patients and their healthcare providers in managing this complex genetic disorder affecting multiple body systems.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 NGS Genetic DNA Test

Comprehensive Introduction to GDF2 Gene Testing

The GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals and families affected by Hereditary Hemorrhagic Telangiectasia (HHT). This sophisticated test specifically targets mutations in the GDF2 gene, which plays a critical role in vascular development and maintenance. HHT5 is a rare autosomal dominant disorder characterized by abnormal blood vessel formation, leading to potentially serious complications if left undiagnosed.

Our advanced Next-Generation Sequencing (NGS) technology provides unparalleled accuracy in detecting GDF2 gene variants, offering patients and healthcare providers definitive diagnostic information. This test is particularly important because early detection of HHT5 can significantly improve patient outcomes through proactive management and preventive care strategies.

What the Test Measures and Detects

The GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 NGS Genetic DNA Test employs cutting-edge molecular diagnostics to:

  • Sequence the entire GDF2 gene coding region with high precision
  • Identify pathogenic variants, including missense, nonsense, and frameshift mutations
  • Detect small insertions and deletions that may disrupt normal gene function
  • Analyze splice site variants that could affect protein production
  • Provide comprehensive variant interpretation by board-certified genetic specialists

Who Should Consider This Genetic Test

Clinical Indications and Symptoms

This test is recommended for individuals presenting with:

  • Recurrent, spontaneous nosebleeds (epistaxis) beginning in childhood or adolescence
  • Visible telangiectasias (small blood vessel malformations) on skin and mucous membranes
  • Family history of Hereditary Hemorrhagic Telangiectasia
  • Unexplained gastrointestinal bleeding or iron-deficiency anemia
  • Suspected arteriovenous malformations (AVMs) in lungs, liver, or brain
  • Migraine headaches or neurological symptoms potentially related to vascular abnormalities
  • Unexplained strokes or transient ischemic attacks in young individuals

Significant Benefits of GDF2 Genetic Testing

Undergoing the GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 NGS Genetic DNA Test provides numerous advantages:

  • Definitive Diagnosis: Confirms or rules out HHT5 with high accuracy
  • Family Risk Assessment: Enables cascade testing for at-risk relatives
  • Personalized Management: Guides appropriate screening and surveillance protocols
  • Reproductive Planning: Informs family planning decisions
  • Early Intervention: Facilitates timely treatment to prevent complications
  • Peace of Mind: Reduces uncertainty and anxiety about symptoms

Understanding Your Test Results

Our comprehensive genetic counseling support helps patients interpret their results effectively:

  • Positive Result: Indicates a pathogenic mutation in the GDF2 gene, confirming HHT5 diagnosis and necessitating specialized medical follow-up
  • Negative Result: Suggests no detectable mutation in the GDF2 gene, though clinical evaluation remains important
  • Variant of Uncertain Significance (VUS): Requires additional family studies and ongoing monitoring as research evolves
  • Carrier Status: Important information for family planning and genetic counseling

Test Information and Pricing

Test Component Details
Test Name GDF2 Gene Hereditary Hemorrhagic Telangiectasia Type 5 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures accessible genetic testing services nationwide.

Take Control of Your Genetic Health Today

Don’t let uncertainty about Hereditary Hemorrhagic Telangiectasia Type 5 affect your quality of life. Our comprehensive GDF2 genetic testing provides the clarity you need for informed healthcare decisions. With our discounted price of only $500 USD, advanced genetic testing is more accessible than ever.

Call us now at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our genetic specialists are available to answer your questions and guide you through the testing process with compassion and expertise.

Take the first step toward understanding your genetic health and securing your family’s future. Contact us today to begin your journey to genetic clarity and personalized medical care.